Guías Clínicas
Guías tam izaje, d iagn óstico y tratam ien to de l hepa toca rcinoma - Sociedad Chilena de Gastroenterología
an Ideal Meta-Analysis. Liver Transpl.
2017;23:836-84.
207.- Bigourdan J, Jaeck D, Meyer N, Meyer
C, Oussoultzoglou E, Bachellier P, et
al. Small Hepatocellular Carcinoma
in Child A Cirrhotic Patients: Hepatic
Resection Versus Transplantation. Liver
Transpl. 2003;9:513-20.
208.- Shah S, Cleary S, Tan J, Wei A,
Gallinger S, Grant D, et al. An Analysis
of Resection vs Transplantation for Early
Hepatocellular Carcinoma: Defining the
Optimal Therapy at a Single Institution.
Ann Surg Oncol. 2007;14:2608-14.
209.- Poon RTP, Fan ST, Lo CM, Liu
CL, Wong J. Difference in Tumor
Invasiveness in Cirrhotic Patients With
Hepatocellular Carcinoma Fulfilling the
Milan Criteria Treated by Resection and
Transplantation: Impact on Long-term
Survival. Ann Surg. 2007;245:51-8.
210.- Baccarani U, Isola M, Adani GL,
Benzoni E, Avellini C, Lorenzin D, et
al. Superiority of Transplantation Versus
Resection for the Treatment of Small
Hepatocellular Carcinoma. Transpl Int.
2008;21:247-54.
211.- Del Gaudio M, Ercolani G, Ravaioli
M, Cescon M, Lauro A, Vivarelli M, et
al. Liver Transplantation for Recurrent
Hepatocellular Carcinoma on Cirrhosis
After Liver Resection : University of
Bologna Experience. Am J Transpl.
2008;8:1177-85.
212.- Koniaris LG, Levi DM, Pedroso FE,
Franceschi D, Tzakis AG, Santamariabarria
104
JA, et al. Is Surgical Resection
Superior to Transplantation in the
Treatment of Hepatocellular Carcinoma?
Ann Surg. 2011;254:527-38.
213.- Adam R, Bhangui P, Vibert E, Azoulay
D, Pelletier G, Duclos-Vall´ee J-C, et
al. Resection or Transplantation for
Early Hepatocellular Carcinoma in a
Cirrhotic Liver: Does Size Define the
Best Oncological Strategy? Ann Surg.
2012;256:883-91.
214.- Sogawa H, Shrager B, Jibara G,
Tabrizian P, Roayaie S, Schwartz
M. Resection or Transplant-listing
for Solitary Hepatitis C-Associated
Hepatocellular Carcinoma: An Intentionto
treat Analysis. HPB. 2013;15:134-41.
215.- Sapisochin G, Castells L, Dopazo C.
Single CHC in Cirrhotic Patients: Liver
Resection or Liver Transplantation ?
Long-term Outcome According to an
Intention-to-treat Basis. Ann Surg Oncol.
2013;20:1194-202.
216.- Jiang L, Liao A, Wen T, Yan L,
Li B, Yang J. Living Donor Liver
Transplantation or Resection for Child-
Pugh A Hepatocellular Carcinoma
Patients with Multiple Nodules
Meeting the Milan Criteria. Transpl Int.
2014;27:562-9.
217.- Llovet JM, Bruix J. Systematic
Review of Randomized Trials for
Unresectable Hepatocellular Carcinoma:
Chemoembolization Improves Survival.
Hepatology. 2003;37:429-42.
218.- Oliveri R, Wetterslev J, Gluud C.
Transarterial (Chemo) embolisation for
Unresectable Hepatocellular Carcinoma
(Review). Cochrane Database Syst Rev.
2011;(3):1-60.
219.- Kluger MD, Halazun KJ, Barroso
RT, Fox AN, Olsen SK, Madoff DC,
et al. Bland Embolization Versus
Chemoembolization of Hepatocellular
Carcinoma Before Transplantation. Liver
Transpl. 2014;20:536-43.
220.- Massarweh NN, Davila JA, Elserag
HB, Duan Z, Temple S, May
S, et al. Transarterial Bland Versus
Chemoembolization for Hepatocellular
Carcinoma: Rethinking a Gold Standard.
J Surg Res. 2016;200:552-9.
221.- Brown KT, Do RK, Gonen M, Covey
AM, Getrajdman GI, Sofocleous CT,
et al. Randomized Trial of Hepatic
Artery Embolization for Hepatocellular
Carcinoma Using Doxorubicin-
Eluting Microspheres Compared With
Embolization With Microspheres Alone.
J Clin Oncol. 2016;34:2046-53.
222.- Lobo L, Yakoub D, Picado O,
Ripat C, Pendola F, Sharma R, et
al. Unresectable Hepatocellular
Carcinoma: Radioembolization Versus
Chemoembolization: A Systematic
Review and Meta- analysis. Cardiovasc
Interv Radiol. 2016;39:1580-8.
223.- Katsanos K, Kitrou P, Spiliopoulos
S, Maroulis I, Petsas T, Karnabatidis
D. Comparative Effectiveness of
Different Transarterial Embolization
Therapies Alone or in Combination
with Local Ablative or Adjuvant
Systemic Treatments for Unresectable
Hepatocellular Carcinoma: A Network
Meta- Analysis of Randomized
Controlled Trials. PLoS One.
2017;12:e0184597.
224.- Yao FY, Mehta N, Flemming J, Dodge
J, Hameed B, Fix O, et al. Downstaging
of Hepatocellular Cancer Before
Liver Transplant: Long-term Outcome
Compared to Tumors within Milan
Criteria. Hepatology. 2015;61:1968-77.
225.- Ravaioli M, Grazi GL, Piscaglia F,
Trevisani F, Cescon M, Ercolani G, et al.
Liver Transplantation for Hepatocellular
Carcinoma: Results of Down-Staging
in Patients Initially Outside the Milan
Selection Criteria. Am J Transplant.
2008;8:2547-57.
226.- Parikh ND, Waljee AK, Singal
AG. Downstaging Hepatocellular
Carcinoma: A Systematic Review and
Pooled Analysis. Liver Transplant.
2015;21:1142-52.
227.- Chapman WC, García-Aroz S,
Vachharajani N, Fowler K, Saad N,
Lin Y, et al. Liver Transplantation for
Advanced Hepatocellular Carcinoma
After Downstaging Without Up-Front
Stage Restrictions. J Am Coll Surg.
2017;224:610-21.
228.- Gordon-Weeks AN, A.Snaith,
T.Petrinic, Friend PJ, Burls A, Silva
MA. Systematic Review of Outcome
of Downstaging Hepatocellular Cancer
Before Liver Transplantation in Patients
Outside the Milan Criteria. Br J
ofSurgery. 2011;98:1201-8.
229.- Murali AR, Romero-marrero C, Miller
C, Aucejo F, Levitin A, Gill A, et al.
Predictors of Successful Downstaging
of Hepatocellular Carcinoma Outside
Milan Criteria. Transplantation.
2016;100:2391-7.
230.- Barakat O, Wood RP, Ozaki CF,
Ankoma-sey V, Galati J, Skolkin
M, et al. Morphological Features of
Advanced Hepatocellular Carcinoma as
a Predictor of Downstaging and Liver
Transplantation: An Intention-to-Treat
Analysis. Liver Transplant. 2010;16:289-
99.
231.- Jang JW, You CR, Kim CW, Bae SH,
Yoon SK, Yoo YK, et al. Benefit of
Downsizing Hepatocellular Carcinoma
in a Liver Transplant Population.
Aliment Pharmacol Ther. 2010;31:415-
23.
232.- De Luna W, Sze DY, Ahmed A, Ha BY,
Ayoub W, Keeffe EB, et al. Transarterial
Gastroenterol. latinoam 2019; Vol 30, Nº 2: 64-106